Proteases in Pemphigoid Diseases
Pemphigoid diseases are a subgroup of autoimmune skin diseases characterized by widespread tense blisters. Standard of care typically involves immunosuppressive treatments, which may be insufficient and are often associated with significant adverse events. As such, a deeper understanding of the path...
Main Authors: | Sho Hiroyasu, Christopher T. Turner, Katlyn C. Richardson, David J. Granville |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-06-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2019.01454/full |
Similar Items
Similar Items
-
Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases
by: Saeedeh Ghorbanalipoor, et al.
Published: (2022-09-01) -
Corrigendum: Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases
by: Saeedeh Ghorbanalipoor, et al.
Published: (2022-11-01) -
Immunofluorescence testing in the diagnosis of autoimmune blistering diseases: overview of 10-year experience
by: Samia Trigo Arbache, et al.
Published: (2014-12-01) -
Rituximab Therapy for Mucous Membrane Pemphigoid: A Retrospective Monocentric Study With Long-Term Follow-Up in 109 Patients
by: Gérôme Bohelay, et al.
Published: (2022-06-01) -
A Retrospective Study of Patient-Reported Data of Bullous Pemphigoid and Mucous Membrane Pemphigoid From a US-Based Registry
by: Janet Lee, et al.
Published: (2019-09-01)